Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BicycleTx Limited
Maastricht University Medical Center
TCR2 Therapeutics
Incyte Corporation
Incyte Corporation
Toray Industries, Inc
Compugen Ltd
Purple Biotech Ltd.
Eli Lilly and Company
Astellas Pharma Inc
Fate Therapeutics
Incyte Corporation
Five Prime Therapeutics, Inc.
ExcellaBio LLC